Emerging methodologies for pathogen identification in positive blood culture testing.

Area of Science:

• Clinical microbiology
• Infectious diseases
• Diagnostic technology

Background:

• Bloodstream infections (BSIs) are a leading cause of mortality and long-term disability.
• Blood culture is the standard diagnostic method but suffers from long turnaround times.
• Delayed diagnosis of BSIs can lead to increased mortality, antibiotic resistance, and higher healthcare costs.

Purpose of the Study:

• To review recent advancements in the early diagnosis of bloodstream infections.
• To present future perspectives on innovative high-throughput technologies for BSI detection.
• To highlight the impact of new diagnostic tools on clinical practice.

Main Methods:

• Review of recent literature on molecular diagnostic tools for BSIs.
• Analysis of the role of MALDI-TOF mass spectrometry in microbiology.
• Discussion of emerging high-throughput technologies for pathogen identification and antibiotic resistance gene detection.

Main Results:

• Molecular tools enable early identification of sepsis pathogens and antibiotic resistance genes.
• MALDI-TOF has significantly reduced time-to-result in routine microbiology.
• Advancements offer alternatives to traditional blood cultures for faster BSI diagnosis.

Conclusions:

• Rapid BSI diagnosis is essential for effective patient management and combating antibiotic resistance.
• Molecular and mass spectrometry-based technologies represent significant progress in BSI diagnostics.
• Future innovations in high-throughput technologies promise further improvements in early BSI detection.